{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:19:26Z","timestamp":1794406766103,"version":"4.9.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Necroptosis is a form of regulated necrosis and is executed by MLKL when MLKL is engaged in triggering the rupture of cell plasma membrane. MLKL activation also leads to the protease, ADAMs-mediated ectodomain shedding of cell surface proteins of necroptotic cells. Tumor necroptosis often happens in advanced solid tumors, and blocking necroptosis by MLKL deletion in breast cancer dramatically reduces tumor metastasis. It has been suggested that tumor necroptosis affects tumor progression through modulating the tumor microenvironment. However, the exact mechanism by which tumor necroptosis promotes tumor metastasis remains elusive. Here, we report that the ectodomain shedding of cell surface proteins of necroptotic cells is critical for the promoting effect of tumor necroptosis in tumor metastasis through inhibiting the anti-tumor activity of T cells. We found that blocking tumor necroptosis by MLKL deletion led to the dramatic reduction of tumor metastasis and significantly elevated anti-tumor activity of tumor-infiltrating and peripheral blood T cells. Importantly, the increased anti-tumor activity of T cells is a key cause for the reduced metastasis as the depletion of CD8+ T cells completely restored the level of metastasis in the Mlkl KO mice. Interestingly, the levels of some soluble cell surface proteins including sE-cadherin that are known to promote metastasis are also dramatically reduced in MLKL null tumors\/mice. Administration of ADAMs pan inhibitor reduces the levels of soluble cell surface proteins in WT tumors\/mice and leads to the dramatic decrease in metastasis. Finally, we showed the sE-cadherin\/KLRG1 inhibitory receptor is the major pathway for necroptosis-mediated suppression of the anti-tumor activity of T cells and the promotion of metastasis. Hence, our study reveals a novel mechanism of tumor necroptosis-mediated promotion of metastasis and suggests that tumor necroptosis and necroptosis-activated ADAMs are potential targets for controlling metastasis.<\/jats:p>","DOI":"10.1186\/s13058-023-01604-9","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T15:02:55Z","timestamp":1674745375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Tumor necroptosis-mediated shedding of cell surface proteins promotes metastasis of breast cancer by suppressing anti-tumor immunity"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhaoshan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Choksi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Joon","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delong","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"key":"1604_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.cell.2019.04.024","volume":"177","author":"DR Green","year":"2019","unstructured":"Green DR. The coming decade of cell death research: five riddles. Cell. 2019;177:1094\u2013107.","journal-title":"Cell"},{"key":"1604_CR2","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.cell.2008.12.004","volume":"135","author":"L Galluzzi","year":"2008","unstructured":"Galluzzi L, Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell. 2008;135:1161\u20133.","journal-title":"Cell"},{"key":"1604_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ceb.2009.12.003","volume":"22","author":"DE Christofferson","year":"2010","unstructured":"Christofferson DE, Yuan JY. Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol. 2010;22:263\u20138.","journal-title":"Curr Opin Cell Biol"},{"key":"1604_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/82732","volume":"1","author":"N Holler","year":"2000","unstructured":"Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000;1:489\u201395.","journal-title":"Nat Immunol"},{"key":"1604_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2008.03.036","volume":"133","author":"L Wang","year":"2008","unstructured":"Wang L, Du F, Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell. 2008;133:693\u2013703.","journal-title":"Cell"},{"key":"1604_CR6","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","volume":"137","author":"S He","year":"2009","unstructured":"He S, Wang L, Miao L, Wang T, Du F, Zhao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell. 2009;137:1100\u201311.","journal-title":"Cell"},{"key":"1604_CR7","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","volume":"137","author":"YS Cho","year":"2009","unstructured":"Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell. 2009;137:1112\u201323.","journal-title":"Cell"},{"key":"1604_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1126\/science.1172308","volume":"325","author":"DW Zhang","year":"2009","unstructured":"Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science. 2009;325:332\u20136.","journal-title":"Science"},{"key":"1604_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","volume":"148","author":"L Sun","year":"2012","unstructured":"Sun L, Wang H, Wang Z, He S, Chen S, Liao D, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell. 2012;148:213\u201327.","journal-title":"Cell"},{"key":"1604_CR10","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.1073\/pnas.1200012109","volume":"109","author":"J Zhao","year":"2012","unstructured":"Zhao J, Jitkaew S, Cai Z, Choksi S, Li Q, Luo J, et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc Natl Acad Sci USA. 2012;109:5322\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1604_CR11","doi-asserted-by":"publisher","first-page":"eaar2188","DOI":"10.1126\/scisignal.aar2188","volume":"11","author":"S Raju","year":"2018","unstructured":"Raju S, Whalen DM, Mengistu M, Swanson C, Quinn JG, Taylor SS, et al. Kinase domain dimerization drives RIPK3-dependent necroptosis. Sci Signal. 2018;11:eaar2188.","journal-title":"Sci Signal"},{"key":"1604_CR12","doi-asserted-by":"crossref","unstructured":"Cai ZY, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J, et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat Cell Biol 2014;16:55-+","DOI":"10.1038\/ncb2883"},{"key":"1604_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","volume":"54","author":"HY Wang","year":"2014","unstructured":"Wang HY, Sun LM, Su LJ, Rizo J, Liu L, Wang LF, et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell. 2014;54:133\u201346.","journal-title":"Mol Cell"},{"key":"1604_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.celrep.2014.04.026","volume":"7","author":"Y Dondelinger","year":"2014","unstructured":"Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I, et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep. 2014;7:971\u201381.","journal-title":"Cell Rep"},{"key":"1604_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/cr.2013.171","volume":"24","author":"X Chen","year":"2014","unstructured":"Chen X, Li W, Ren J, Huang D, He WT, Song Y, et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res. 2014;24:105\u201321.","journal-title":"Cell Res"},{"key":"1604_CR16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.chom.2012.01.016","volume":"11","author":"JW Upton","year":"2012","unstructured":"Upton JW, Kaiser WJ, Mocarski ES. DAI\/ZBP1\/DLM-1 complexes with RIP3 to mediate virus-induced programmed necrosis that is targeted by murine cytomegalovirus vIRA. Cell Host Microbe. 2012;11:290\u20137.","journal-title":"Cell Host Microbe"},{"key":"1604_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.immuni.2013.02.003","volume":"38","author":"A Kaczmarek","year":"2013","unstructured":"Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity. 2013;38:209\u201323.","journal-title":"Immunity"},{"key":"1604_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191\u20135.","journal-title":"Nature"},{"key":"1604_CR19","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1038\/s41467-021-23004-3","volume":"12","author":"JY Baik","year":"2021","unstructured":"Baik JY, Liu Z, Jiao D, Kwon HJ, Yan J, Kadigamuwa C, et al. ZBP1 not RIPK1 mediates tumor necroptosis in breast cancer. Nat Commun. 2021;12:2666.","journal-title":"Nat Commun"},{"key":"1604_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.semcdb.2008.11.002","volume":"20","author":"K Reiss","year":"2009","unstructured":"Reiss K, Saftig P. The, \u201ca disintegrin and metalloprotease\u201d (ADAM) family of sheddases: physiological and cellular functions. Semin Cell Dev Biol. 2009;20:126\u201337.","journal-title":"Semin Cell Dev Biol"},{"key":"1604_CR21","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/cr.2016.87","volume":"26","author":"ZY Cai","year":"2016","unstructured":"Cai ZY, Zhang AL, Choksi S, Li WH, Li T, Zhang XM, et al. Activation of cell-surface proteases promotes necroptosis, inflammation and cell migration. Cell Res. 2016;26:886\u2013900.","journal-title":"Cell Res"},{"key":"1604_CR22","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1158\/0008-5472.CAN-11-3498","volume":"72","author":"JM David","year":"2012","unstructured":"David JM, Rajasekaran AK. Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments. Can Res. 2012;72:2917\u201323.","journal-title":"Can Res"},{"key":"1604_CR23","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1182\/blood.V100.2.610","volume":"100","author":"Y Yang","year":"2002","unstructured":"Yang Y, Yaccoby S, Liu W, Langford JK, Pumphrey CY, Theus A, et al. Soluble syndecan-1 promotes growth of myeloma tumors in vivo. Blood. 2002;100:610\u20137.","journal-title":"Blood"},{"key":"1604_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13058-018-1064-1","volume":"20","author":"AO Leech","year":"2018","unstructured":"Leech AO, Vellanki SH, Rutherford EJ, Keogh A, Jahns H, Hudson L, et al. Cleavage of the extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2 therapies in breast cancer settings. Breast Cancer Res. 2018;20:140.","journal-title":"Breast Cancer Res"},{"key":"1604_CR25","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/gut.48.6.808","volume":"48","author":"AOO Chan","year":"2001","unstructured":"Chan AOO, Lam SK, Chu KM, Lam CM, Kwok E, Leung SY, et al. Soluble E-cadherin is a valid prognostic marker in gastric carcinoma. Gut. 2001;48:808\u201311.","journal-title":"Gut"},{"key":"1604_CR26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/cncr.21260","volume":"104","author":"AOO Chan","year":"2005","unstructured":"Chan AOO, Chu KM, Lam SK, Cheung KL, Law S, Kwok KF, et al. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin. Cancer. 2005;104:740\u20136.","journal-title":"Cancer"},{"key":"1604_CR27","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1002\/ijc.29982","volume":"138","author":"QP Hu","year":"2016","unstructured":"Hu QP, Kuang JY, Yang QK, Bian XW, Yu SC. Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer. Int J Cancer. 2016;138:2804\u201312.","journal-title":"Int J Cancer"},{"key":"1604_CR28","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1002\/eji.200838690","volume":"38","author":"S Rosshart","year":"2008","unstructured":"Rosshart S, Hofmann M, Schweier O, Pfaff AK, Yoshimoto K, Takeuchi T, et al. Interaction of KLRG1 with E-cadherin: new functional and structural insights. Eur J Immunol. 2008;38:3354\u201364.","journal-title":"Eur J Immunol"},{"key":"1604_CR29","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1182\/blood-2010-12-321588","volume":"117","author":"H Streeck","year":"2011","unstructured":"Streeck H, Kwon DS, Pyo A, Flanders M, Chevalier MF, Law K, et al. Epithelial adhesion molecules can inhibit HIV-1-specific CD8(+) T-cell functions. Blood. 2011;117:5112\u201322.","journal-title":"Blood"},{"key":"1604_CR30","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41422-018-0058-y","volume":"28","author":"DL Jiao","year":"2018","unstructured":"Jiao DL, Cai ZY, Choksi S, Ma D, Choe M, Kwon HJ, et al. Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis. Cell Res. 2018;28:868\u201370.","journal-title":"Cell Res"},{"key":"1604_CR31","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.cell.2016.01.049","volume":"164","author":"AK Palucka","year":"2016","unstructured":"Palucka AK, Coussens LM. The basis of oncoimmunology. Cell. 2016;164:1233\u201347.","journal-title":"Cell"},{"key":"1604_CR32","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/nm.2830","volume":"18","author":"BN Bidwell","year":"2012","unstructured":"Bidwell BN, Slaney CY, Withana NP, Forster S, Cao Y, Loi S, et al. Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape. Nat Med. 2012;18:1224\u201331.","journal-title":"Nat Med"},{"key":"1604_CR33","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/S0002-9440(10)63568-7","volume":"163","author":"EY Lin","year":"2003","unstructured":"Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol. 2003;163:2113\u201326.","journal-title":"Am J Pathol"},{"key":"1604_CR34","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1038\/onc.2015.429","volume":"35","author":"P Trikha","year":"2016","unstructured":"Trikha P, Sharma N, Pena C, Reyes A, Pecot T, Khurshid S, et al. E2f3 in tumor macrophages promotes lung metastasis. Oncogene. 2016;35:3636\u201346.","journal-title":"Oncogene"},{"key":"1604_CR35","doi-asserted-by":"crossref","unstructured":"Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc 2008;2008:pdb prot4986","DOI":"10.1101\/pdb.prot4986"},{"key":"1604_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/0192623315625859","volume":"44","author":"SA Elmore","year":"2016","unstructured":"Elmore SA, Dixon D, Hailey JR, Harada T, Herbert RA, Maronpot RR, et al. Recommendations from the INHAND apoptosis\/necrosis working group. Toxicol Pathol. 2016;44:173\u201388.","journal-title":"Toxicol Pathol"},{"key":"1604_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/stem.324","volume":"28","author":"CH Stuelten","year":"2010","unstructured":"Stuelten CH, Mertins SD, Busch JI, Gowens M, Scudiero DA, Burkett MW, et al. Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel. Stem Cells. 2010;28:649\u201360.","journal-title":"Stem Cells"},{"key":"1604_CR38","doi-asserted-by":"publisher","first-page":"eaaw2004","DOI":"10.1126\/sciimmunol.aaw2004","volume":"4","author":"AG Snyder","year":"2019","unstructured":"Snyder AG, Hubbard NW, Messmer MN, Kofman SB, Hagan CE, Orozco SL, et al. Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity. Sci Immunol. 2019;4:eaaw2004.","journal-title":"Sci Immunol"},{"issue":"757\u201374","key":"1604_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11010007","volume":"34","author":"W Wang","year":"2018","unstructured":"Wang W, Marinis JM, Beal AM, Savadkar S, Wu Y, Khan M, et al. RIP1 kinase drives macrophage-mediated adaptive immune tolerance in pancreatic cancer. Cancer Cell. 2018;34(757\u201374): e7.","journal-title":"Cancer Cell"},{"key":"1604_CR40","doi-asserted-by":"crossref","unstructured":"Vodnala SK, Eil R, Kishton RJ, Sukumar M, Yamamoto TN, Ha NH, et al. T cell stemness and dysfunction in tumors are triggered by a common mechanism. Science 2019;363:1417-+","DOI":"10.1126\/science.aau0135"},{"key":"1604_CR41","doi-asserted-by":"crossref","unstructured":"Michael J. Parnham FPN, Adriano G. Rossi. Nijkamp and Parnham\u2019s principles of immunopharmacology. 2018.","DOI":"10.1007\/978-3-030-10811-3"},{"key":"1604_CR42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11357-009-9100-9","volume":"31","author":"SM Henson","year":"2009","unstructured":"Henson SM, Akbar AN. KLRG1-more than a marker for T cell senescence. Age. 2009;31:285\u201391.","journal-title":"Age"},{"key":"1604_CR43","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.4049\/jimmunol.176.3.1311","volume":"176","author":"C Grundemann","year":"2006","unstructured":"Grundemann C, Bauer M, Schweier O, von Oppen N, Lassing U, Saudan P, et al. Cutting edge: Identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1. J Immunol. 2006;176:1311\u20135.","journal-title":"J Immunol"},{"key":"1604_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/intimm\/dxm004","volume":"19","author":"MS Tessmer","year":"2007","unstructured":"Tessmer MS, Fugere C, Stevenaert F, Naidenko OV, Chong HJ, Leclercq G, et al. KLRG1 binds cadherins and preferentially associates with SHIP-1. Int Immunol. 2007;19:391\u2013400.","journal-title":"Int Immunol"},{"key":"1604_CR45","doi-asserted-by":"publisher","first-page":"117437","DOI":"10.1016\/j.lfs.2020.117437","volume":"247","author":"S Bastaki","year":"2020","unstructured":"Bastaki S, Irandoust M, Ahmadi A, Hojjat-Farsangi M, Ambrose P, Hallaj S, et al. PD-L1\/PD-1 axis as a potent therapeutic target in breast cancer. Life Sci. 2020;247:117437.","journal-title":"Life Sci"},{"key":"1604_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/or.2020.7831","volume":"45","author":"CJ Li","year":"2021","unstructured":"Li CJ, Lin LT, Hou MF, Chu PY. PD-L1\/PD-1 blockade in breast cancer: the immunotherapy era. Oncol Rep. 2021;45:5\u201312.","journal-title":"Oncol Rep"},{"key":"1604_CR47","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ncb3015","volume":"16","author":"SS McAllister","year":"2014","unstructured":"McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014;16:717\u201327.","journal-title":"Nat Cell Biol"},{"key":"1604_CR48","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","volume":"529","author":"J Massague","year":"2016","unstructured":"Massague J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature. 2016;529:298\u2013306.","journal-title":"Nature"},{"key":"1604_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrc1367","volume":"4","author":"JM Brown","year":"2004","unstructured":"Brown JM, William WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer. 2004;4:437\u201347.","journal-title":"Nat Rev Cancer"},{"key":"1604_CR50","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891\u20139.","journal-title":"Nat Rev Cancer"},{"key":"1604_CR51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3892\/ol.2011.420","volume":"3","author":"R Caruso","year":"2012","unstructured":"Caruso R, Parisi A, Bonanno A, Paparo D, Quattrocchi E, Branca G, et al. Histologic coagulative tumour necrosis as a prognostic indicator of aggressiveness in renal, lung, thyroid and colorectal carcinomas: a brief review. Oncol Lett. 2012;3:16\u20138.","journal-title":"Oncol Lett"},{"key":"1604_CR52","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.2217\/fon.11.99","volume":"7","author":"CH Richards","year":"2011","unstructured":"Richards CH, Mohammed Z, Qayyum T, Horgan PG, McMillan DC. The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review. Future Oncol. 2011;7:1223\u201335.","journal-title":"Future Oncol"},{"key":"1604_CR53","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.trecan.2017.03.002","volume":"3","author":"A Najafov","year":"2017","unstructured":"Najafov A, Chen HB, Yuan JY. Necroptosis and cancer. Trends Cancer. 2017;3:294\u2013301.","journal-title":"Trends Cancer"},{"key":"1604_CR54","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","volume":"19","author":"X Wei","year":"2022","unstructured":"Wei X, Xie F, Zhou XX, Wu YC, Yan HY, Liu T, et al. Role of pyroptosis in inflammation and cancer. Cell Mol Immunol. 2022;19:971\u201392.","journal-title":"Cell Mol Immunol"},{"key":"1604_CR55","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.trecan.2021.09.003","volume":"8","author":"J Yan","year":"2022","unstructured":"Yan J, Wan PX, Choksi S, Liu ZG. Necroptosis and tumor progression. Trends Cancer. 2022;8:21\u20137.","journal-title":"Trends Cancer"},{"key":"1604_CR56","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature17403","volume":"532","author":"L Seifert","year":"2016","unstructured":"Seifert L, Werba G, Tiwari S, Giao Ly NN, Alothman S, Alqunaibit D, et al. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016;532:245\u20139.","journal-title":"Nature"},{"key":"1604_CR57","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41418-019-0347-0","volume":"27","author":"S Patel","year":"2020","unstructured":"Patel S, Webster JD, Varfolomeev E, Kwon YC, Cheng JH, Zhang J, et al. RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases. Cell Death Differ. 2020;27:161\u201375.","journal-title":"Cell Death Differ"},{"key":"1604_CR58","doi-asserted-by":"crossref","unstructured":"Bengsch B, Seigel B, Ruhl M, Timm J, Kuntz M, Blum HE, et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-Specific CD8+T cells is linked to antigen recognition and T cell differentiation. PLoS Pathogens 2010;6","DOI":"10.1371\/journal.ppat.1000947"},{"key":"1604_CR59","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.tube.2015.11.008","volume":"97","author":"MC Boer","year":"2016","unstructured":"Boer MC, van Meijgaarden KE, Goletti D, Vanini V, Prins C, Ottenhoff THM, et al. KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults. Tuberculosis. 2016;97:163\u201371.","journal-title":"Tuberculosis"},{"key":"1604_CR60","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41590-022-01170-w","volume":"23","author":"JA Perry","year":"2022","unstructured":"Perry JA, Shallberg L, Clark JT, Gullicksrud JA, DeLong JH, Douglas BB, et al. PD-L1-PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infection. Nat Immunol. 2022;23:743\u201356.","journal-title":"Nat Immunol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-023-01604-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-023-01604-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-023-01604-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T16:09:05Z","timestamp":1674749345000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-023-01604-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1604"],"URL":"https:\/\/doi.org\/10.1186\/s13058-023-01604-9","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]},"assertion":[{"value":"26 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the National Cancer Institute Animal Care and Use Committee (NCI-ACUC), and the study followed NIH guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not include any human study, and therefore, consent for publication is not applicable in this case. All authors listed approved the present manuscript and consented for its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}